| scholarly article | Q13442814 |
| P2093 | author name string | Yechezkel Barenholz | |
| Olga Garbuzenko | |||
| Aba Priev | |||
| P433 | issue | 2 | |
| P304 | page(s) | 117-129 | |
| P577 | publication date | 2005-03-02 | |
| P1433 | published in | Chemistry and Physics of Lipids | Q15746139 |
| P1476 | title | Effect of grafted PEG on liposome size and on compressibility and packing of lipid bilayer | |
| P478 | volume | 135 |
| Q42392490 | A Mixed Micelle Formulation for Oral Delivery of Vitamin K |
| Q36392418 | A Novel Approach on Drug Delivery: Investigation of A New Nano-Formulation of Liposomal Doxorubicin and Biological Evaluation of Entrapped Doxorubicin on Various Osteosarcoma Cell Lines |
| Q36110850 | A detachable coating of cholesterol-anchored PEG improves tumor targeting of cell-penetrating peptide-modified liposomes |
| Q44638571 | AFM phase imaging of soft-hydrated samples: a versatile tool to complete the chemical-physical study of liposomes |
| Q35624235 | Accelerated blood clearance phenomenon upon cross-administration of PEGylated nanocarriers in beagle dogs |
| Q39739004 | Bisphosphonate-coated BSA nanoparticles lack bone targeting after systemic administration |
| Q28542784 | Brain-targeted delivery of trans-activating transcriptor-conjugated magnetic PLGA/lipid nanoparticles |
| Q35785890 | Calcium phosphate nanoparticles with an asymmetric lipid bilayer coating for siRNA delivery to the tumor |
| Q99555850 | Cathepsin B-Responsive Liposomes for Controlled Anticancer Drug Delivery in Hep G2 Cells |
| Q64229959 | Characterization, optimization, and in vitro evaluation of Technetium-99m-labeled niosomes |
| Q92236729 | Cholesterol-rich lipid-mediated nanoparticles boost of transfection efficiency, utilized for gene editing by CRISPR-Cas9 |
| Q64990329 | Colloid supported lipid bilayers for self-assembly. |
| Q37175322 | Development of a bone-targeted pH-sensitive liposomal formulation containing doxorubicin: physicochemical characterization, cytotoxicity, and biodistribution evaluation in a mouse model of bone metastasis |
| Q39014487 | Development of high-content gemcitabine PEGylated liposomes and their cytotoxicity on drug-resistant pancreatic tumour cells. |
| Q64120064 | Effect of Formulation Method, Lipid Composition, and PEGylation on Vesicle Lamellarity: A Small-Angle Neutron Scattering Study |
| Q90332286 | Effect of PEGylation on Ligand-Targeted Magnetoliposomes: A Missed Goal |
| Q50503418 | Effect of PEGylation on biodistribution and gene silencing of siRNA/lipid nanoparticle complexes. |
| Q38403588 | Effect of size and pegylation of liposomes and peptide-based synthetic lipoproteins on tumor targeting |
| Q51034706 | Effects of various spacers between biotin and the phospholipid headgroup on immobilization and sedimentation of biotinylated phospholipid-containing liposomes facilitated by avidin-biotin interactions. |
| Q38027231 | Emerging role of radiolabeled nanoparticles as an effective diagnostic technique |
| Q35916173 | Endosomal escape and transfection efficiency of PEGylated cationic liposome-DNA complexes prepared with an acid-labile PEG-lipid. |
| Q35087556 | Enhanced siRNA delivery into cells by exploiting the synergy between targeting ligands and cell-penetrating peptides |
| Q38910401 | Evaluation of a PSMA-targeted BNF nanoparticle construct. |
| Q28477392 | Fabrication principles and their contribution to the superior in vivo therapeutic efficacy of nano-liposomes remote loaded with glucocorticoids |
| Q35434767 | Fluorescence microscopy colocalization of lipid-nucleic acid nanoparticles with wildtype and mutant Rab5-GFP: A platform for investigating early endosomal events |
| Q28535601 | Glucocorticosteroids in nano-sterically stabilized liposomes are efficacious for elimination of the acute symptoms of experimental cerebral malaria |
| Q45352781 | Hepatocyte targeting using pegylated asialofetuin-conjugated liposomes |
| Q43088674 | Immunogenicity, protective efficacy and mechanism of novel CCS adjuvanted influenza vaccine |
| Q37588032 | Influence of polyethylene glycol density and surface lipid on pharmacokinetics and biodistribution of lipid-calcium-phosphate nanoparticles |
| Q88623451 | Interaction between C18 fatty acids and DOPE PEG2000 in Langmuir monolayers: effect of degree of unsaturation |
| Q41615726 | Interactions between adsorbed hydrogenated soy phosphatidylcholine (HSPC) vesicles at physiologically high pressures and salt concentrations |
| Q37186746 | Lipid nature and their influence on opening of redox-active liposomes |
| Q30366990 | Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come. |
| Q33911056 | Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic |
| Q35088353 | Liposome-based mucus-penetrating particles (MPP) for mucosal theranostics: demonstration of diamagnetic chemical exchange saturation transfer (diaCEST) magnetic resonance imaging (MRI). |
| Q50876699 | Liposomes as potential masking agents in sport doping. Part 2: Detection of liposome-entrapped haemoglobin by flow cytofluorimetry. |
| Q39036112 | Liposomes co-modified with cholesterol anchored cleavable PEG and octaarginines for tumor targeted drug delivery |
| Q38837880 | Monoolein-based nanocarriers for enhanced folate receptor-mediated RNA delivery to cancer cells |
| Q35199349 | Multicomponent folate-targeted magnetoliposomes: design, characterization, and cellular uptake |
| Q39425556 | Multifunctional PEGylated 2C5-immunoliposomes containing pH-sensitive bonds and TAT peptide for enhanced tumor cell internalization and cytotoxicity |
| Q28546214 | Nano-Drugs Based on Nano Sterically Stabilized Liposomes for the Treatment of Inflammatory Neurodegenerative Diseases |
| Q35553193 | Nanoparticle PEGylation for imaging and therapy |
| Q37376443 | Nanoparticles evading the reticuloendothelial system: role of the supported bilayer |
| Q48314799 | New liposomal doxorubicin nanoformulation for osteosarcoma: Drug release kinetic study based on thermo and pH sensitivity |
| Q35576275 | Novel RGD-lipid conjugate-modified liposomes for enhancing siRNA delivery in human retinal pigment epithelial cells |
| Q61808387 | Optimization of Acoustic Liposomes for Improved In Vitro and In Vivo Stability |
| Q42554823 | Polymer-supported lipid shells, onions, and flowers. |
| Q36549331 | Preformulation Studies of a Liposomal Formulation Containing Sirolimus for the Treatment of Dry Eye Disease |
| Q64251080 | Preparation of Benzothiazolyl-Decorated Nanoliposomes |
| Q125572088 | RETRACTED: Liposomes: Structure, Biomedical Applications, and Stability Parameters With Emphasis on Cholesterol |
| Q91789862 | Shape and Phase Transitions in a PEGylated Phospholipid System |
| Q37415968 | Surface engineering of liposomes for stealth behavior |
| Q39662393 | Sustained distribution of aerosolized PEGylated liposomes in epithelial lining fluids on alveolar surfaces |
| Q28659327 | Synthesis, characterization, and evaluation of a novel amphiphilic polymer RGD-PEG-Chol for target drug delivery system |
| Q51136151 | The effect of superparamagnetic iron oxide nanoparticles surface engineering on relaxivity of magnetoliposome. |
| Q28538311 | Therapeutic efficacy of combining pegylated liposomal doxorubicin and radiofrequency (RF) ablation: comparison between slow-drug-releasing, non-thermosensitive and fast-drug-releasing, thermosensitive nano-liposomes |
| Q43842753 | Thermodynamics of Lipid Interactions with Cell-Penetrating Peptides |
| Q30830508 | Tumor-targeted responsive nanoparticle-based systems for magnetic resonance imaging and therapy |
| Q60719584 | pH-Promoted Release of a Novel Anti-Tumour Peptide by “Stealth” Liposomes: Effect of Nanocarriers on the Drug Activity in Cis-Platinum Resistant Cancer Cells |
Search more.